About
Basic Data Updated:
1 month agoThe Corporate was formerly known as Natchem Pharma Pvt Ltd.. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 Lakh and a paid-up capital of Rs 1.02 Lakh, as per the Ministry of Corporate Affairs (MCA) records.
Pathuri Rao and Sadasiva Nannapaneni serve as directors at the Company.
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Website12224421
- Telephone12224421
- Email Address12224421
- Social Media12224421
| CIN/LLPIN/FCRN | U24230TG1989PTC009942 |
| Company No. | 009942 |
| Company Classification | Private Limited Indian Non-Government Company |
| Incorporation Date | 02 May 1989 |
| Date of AGM | 29 Sep 2023 |
| Date of Balance Sheet | 31 Mar 2023 |
| Listing Status | Unlisted |
| ROC Code | Roc Hyderabad |
Financials of Natco Drug Discovery Private Limited
Natco Drug Discovery Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth dipped by a decrease of 0.01%.
Corporate Structure
Unlock access to Natco Drug Discovery's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
People in Natco Drug Discovery Private Limited
Unlock and access historical data on people associated with Natco Drug Discovery, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Board Members(2)
Charges (Loans)
There are no open charges registered against the company as per our records.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Natco Drug Discovery, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Natco Drug Discovery's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alert
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Related Corporates (Common Directorship)
Time Cap Pharma Labs Private Limited
Active
36 years 7 months Sadasiva Nannapaneni is a mutual person
Natsoft Information Systems Private Limited
Active 26 years 2 months Sadasiva Nannapaneni is a mutual person
Recent activity within the organization
Annual General Meeting
Natco Drug Discovery Private Limited last Annual general meeting of members was held on 29 Sep 2023 as per latest MCA records.
29 Sep 2023Balance Sheet
Natco Drug Discovery Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Hyderabad.
31 Mar 2023Director Appointment
Sadasiva Rao Nannapaneni was appointed as a Director was appointed as a Director on 01 Jul 2016 & has been associated with this company since 8 years 2 months .
01 Jul 2016Director Appointment
Pathuri Srinivasa Rao was appointed as a Director was appointed as a Director on 19 Jun 2002 & has been associated with this company since 22 years 3 months .
19 Jun 2002Company Incorporation
Natco Drug Discovery Private Limited was registered on 02 May 1989 with Roc Hyderabad & aged 35 years 4 months as per MCA records.
02 May 1989
Recent News, Updates & Announcement
Operations at Natco Pharma Chennai factory temporarily disrupted due to cyclone.Hyderabad Natco Pharma has announced that the operations at the Companys factory located at Manali Industrial Area Chennai Tamil Nadu have been temporarily disrupted due to cyclone with .
Medical Dialogues 08 Dec 2023
- Natco Pharma Q2 FY24 results profit rise by 54965 YOY Mint.
Natco Pharma Q2 FY24 results Revenue increased by 13869 YoY profit increased by 54965 YoY.
mint 16 Nov 2023
- FDA Slaps Natco With Form 483 Over Contamination Issues Quality Lapses.
FDA News 04 Nov 2023
- Pee Safe raises 3 million in a Series B funding round led by Natco Pharma and Rainmatter Health.
Hygiene and wellness brand Pee Safe has raised 3 million in a Series B funding round led by Natco Pharma Limited and Rainmatter Health The funds will be used to expand the companys retail presence in India expand overseas and allocate additional resources to marketing and awareness initiatives Pee Safe offers a range of personal hygiene products including reusable pads tampons and menstrual cups and aims to address the lack of access to safe menstrual and personal hygiene products for Indian women.
Economic Times 12 Sep 2023
- Natco Pharma others sued in US for generic cancer drug.
The company believes this matter is without merit Natco Pharma said in a statement Breckenridge is the abbreviated new drug application ANDA holder and distribution partner for the generic product in the US it added Natco Pharma shares were trading 313 per cent down at Rs 88500 apiece on the BSE.
Economic Times 09 Sep 2023
Frequently asked questions
What is the Incorporation or founding date of Natco Drug Discovery Private Limited?
